Risk of Serious Infections in Patients with Ulcerative Colitis Treated with Tofacitinib Compared to Biologic Treatments in the United States

被引：0
|
作者：
Rubin, David T. [1 ]
Schreiber, Stefan [2 ]
Peyrin-Biroulet, Laurent [3 ,4 ]
Danese, Silvio [5 ]
Gianfrancesco, Milena [6 ]
Soonasra, Arif [7 ]
Sidhu, Sarah [6 ]
Vranic, Ivana [8 ]
Shelbaya, Ahmed [6 ]
Gruben, David [9 ]
Winthrop, Kevin [10 ]
Curtis, Jeffrey [11 ]
Regueiro, Miguel D. [12 ]
Dubinsky, Marla C. [13 ]
机构：
[1] Univ Chicago Med, Inflammatory Bowel Dis Ctr, Chicago, IL USA
[2] Univ Hosp Schleswig Holstein, Kiel, Germany
[3] Nancy Univ Hosp, INFINY Inst, FHU CURE, INSERM,NGERE, Vand?uvre Ies Nancy, Lorraine, France
[4] McGill Univ, Hlth Ctr, Montreal, PQ, Canada
[5] IRCCS San Raffaele Sci Inst, Milan, Lombardy, Italy
[6] Pfizer Inc, New York, NY USA
[7] Pfizer Inc, Collegeville, PA USA
[8] Pfizer Inc, Walton Oaks, England
[9] Pfizer Inc, Groton, CT USA
[10] Oregon Hlth & Sci Univ, Portland, OR USA
[11] Univ Alabama Birmingham, Birmingham, AL USA
[12] Cleveland Clin, Cleveland, OH USA
[13] Icahn Sch Med Mt Sinai, New York, NY USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期
关键词：
D O I：
10.14309/01.ajg.0001033604.38645.83
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1059
引用
收藏
页码：S746 / S746
页数：1
相关论文
共 50 条
  • [41] The Comparison of Short-Term Efficacy of Treatments Between Tofacitinib and Vedolizumab in Patients With Ulcerative Colitis
    Takada, Yoshiaki
    Naganuma, Makoto
    Mutaguchi, Makoto
    Fukuda, Tomohiro
    Mikami, Yohei
    Hagihara, Yuya
    Tanemoto, Shun
    Umeda, Satoko
    Nomura, Ena
    Yoshida, Kosuke
    Yoshimatsu, Yusuke
    Ono, Keiko
    Sugimoto, Shinya
    Nanki, Kosaku
    Fukuhara, Kayoko
    Sujino, Tomohisa
    Takabayashi, Kaoru
    Ogata, Haruhiko
    Iwao, Yasushi
    Kanai, Takanori
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S24 - S25
  • [42] PROGNOSTIC VALUE OF FECAL CALPROTECTIN IN BIOLOGIC-TREATED PATIENTS WITH ULCERATIVE COLITIS
    Dulai, Parambir S.
    Feagan, Brian G.
    Sands, Bruce E.
    Chen, Jingjing
    Lasch, Karen
    Lirio, Richard A.
    GASTROENTEROLOGY, 2021, 160 (06) : S46 - S47
  • [43] Comorbidity Burden Among Patients With Ulcerative Colitis in the United States
    Pilon, Dominic
    Obando, Camilo
    Ding, Zhijie
    Voelker, Jennifer
    Muser, Erik
    Manceur, Ameur M.
    Kinkead, Frederic
    Lafeuille, Marie-Helene
    Lefebvre, Patrick
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S418 - S418
  • [44] Incidence of venous thromboembolic events in patients with ulcerative colitis treated with tofacitinib in the ulcerative colitis clinical development programme: An update as of May 2019
    Sandborn, W. J.
    Panes, J.
    Sands, B. E.
    Reinisch, W.
    Modesto, I.
    Su, C.
    Steinwurz, F.
    Lawendy, N.
    Koram, N.
    Kwok, K.
    Jones, T. V.
    Thorpe, A. J.
    Quirk, D.
    Danese, S.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S498 - S500
  • [45] Short Disease Duration Is Associated With Increased Risk of Treatment Failure in Biologic-Treated Patients With Ulcerative Colitis
    Nguyen, Nghia H.
    Kurnool, Soumya
    Dulai, Parambir S.
    Boland, Brigid S.
    Sandborn, William J.
    Singh, Siddharth
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (09) : 1429 - 1435
  • [46] INCIDENCE OF VENOUS THROMBOEMBOLIC EVENTS IN PATIENTS WITH ULCERATIVE COLITIS TREATED WITH TOFACITINIB IN THE ULCERATIVE COLITIS CLINICAL DEVELOPMENT PROGRAM: AN UPDATE AS OF MAY 2019
    Sandborn, William J.
    Panes, Julian
    Sands, Bruce E.
    Reinisch, Walter
    Modesto, Irene
    Su, Chinyu
    Steinwurz, Flavio
    Lawendy, Nervin
    Koram, Nana
    Kwok, Kenneth
    Jones, Thomas V.
    Thorpe, Andrew J.
    Quirk, Daniel
    Danese, Silvio
    GASTROENTEROLOGY, 2020, 158 (06) : S144 - S144
  • [47] Risk of serious infections in denosumab-treated patients
    Reactions Weekly, 2020, 1787 (1) : 11 - 11
  • [48] Risk of Serious Infections in Tofacitinib versus Other Biologic Drug Initiators in Patients with Rheumatoid Arthritis: A Multi-database Cohort Study
    Pawar, Ajinkya
    Desai, Rishi
    Gautam, Nileesa
    Kim, Seoyoung C.
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [49] Significant Variation in Biologic Use Across the United States for Crohn's Disease and Ulcerative Colitis
    Siegel, Corey A.
    Yang, Fei
    Cai, John
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S388 - S388
  • [50] Treatment Pathways Leading to Biologic Therapies for Ulcerative Colitis and Crohn's Disease in the United States
    Siegel, Corey A.
    Yang, Fei
    Eslava, Sergio
    Cai, Zhaohui
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2020, 11 : e00128
12345